Mark Eckert, PhDUniversity of Chicago Targeting T-LAK cell-originated protein kinase (TOPK) for ovarian cancer therapy Ovarian cancer is one of the most lethal cancers due to a lack of effective therapies. Dr. Eckert’s lab recently found that the protein T-LAK cell-originated protein kinase (TOPK) is expressed in ovarian cancer cells, but not most normal tissues. […]
Read More
Carrie Rinker-Schaeffer, PhDUniversity of Chicago Milky Spot Macrophages: Co-Conspirators in Omental Metastasis Formation No one knows what microenvironmental interactions control ovarian cancer metastasis. Getting this crucial information requires a fresh look from a new perspective. Recently Dr. Rinker-Schaeffer’s lab made a novel connection between ovarian cancer metastatic colonization and structures on the omentum (tissues in […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).
